Churg Strauss Syndrome Market Scenario
The Churg Strauss Syndrome market is expected to reach 369.29 Million by 2030 at 4.60% CAGR during the forecast period 2022-2030. Churg Strauss syndrome is a disorder that causes inflammation in blood vessels. This restricts the blood flow to vital organs and tissues. Sometimes it leads to permanent damage of tissues. This condition is also known as eosinophilic granulomatosis with polyangiitis. Asthma is the most common sign of churg Strauss syndrome. It also affects nose, sinuses, lung, heart, and nerves. There are no medications on this and while it is rare some people got this disease because of asthma medication called Montelukast. As due to change in environmental conditions lots of people are suffering from allergic and immune disorders. Hence this leads to an increase in the growth of this market.
Factors such as growing occurrences of churg Strauss syndrome and other allergic reactions and asthma, rising geriatric population, and growing incidences of churg Strauss syndrome in children are expected to drive the growth of the market during the assessment period.
On the other hand, the unfavorable reimbursement scenario in many developing countries and lack of awareness regarding
autoimmune disorder in people can hinder the growth of the market during the forecast period.
Segmentation
The churg Strauss syndrome market is segmented on basis of diagnosis, treatment, end users. Based on diagnosis the churg Strauss syndrome market is further segmented into blood test, imaging, biopsy, chest x-ray, CT scan. On basis of treatment, the syndrome is further segmented into biologics, immunoglobulin, corticosteroid, immunosuppressive drugs and others. Immunoglobulin is further sub-segmented into vaccines, steroids, and others. Based on end users the churg Strauss syndrome is further segmented into hospitals, clinics, laboratory, therapeutics aspects, and others.
Key players
Some of the key players in the global churg Strauss syndrome market are Slivergate, Heron Therapeutics, Inc., IRX Therapeutics, Inc., Brabourne Enterprises Ltd, Rupus Research Alliance, Tianjin Tianyao Pharmaceuticals Co., Ltd, and Grifols, S.A.
Regional Market Summary
Churg Strauss Syndrome Global Market Share, by Region, 2018 (%)
Source: MRFR Analysis
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The churg Strauss syndrome market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East and Africa has been segmented into the Middle East and Africa.
Geographically, the Americas is anticipated to dominate the global churg Strauss syndrome market. The market growth in this region is attributed to the increasing asthma patients, change in environmental conditions, increasing allergic reaction and others. Moreover, the increasing incidence of
asthma in the aging population is expected to fuel the growth of the market in this region.
Europe is expected to be the second largest market in the globe owing to the increasing number of hay fever, increasing government expenditure for sinus pain and inflammation, increasing number of people visiting a doctor for allergic reaction problem.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of immunosuppressant disease and hyper-eosinophilia related problems in developing countries and increasing incidences of granulomatosis.
The Middle East and Africa is expected to account for the lowest market share in the global churg Strauss syndrome market due to low development, lack of technical knowledge, and poor medical facilities in developing economies in this region.
Global Churg Strauss Syndrome Market, by Diagnosis
- Blood test
- Imaging
- Biopsy
- Chest X-ray
- CT Sca
Global Churg Strauss Syndrome Market, by treatment
- Biologics
- Immunoglobulin
- Vaccines
- Steroid
- Other
- Corticosteroid
- Immunosuppressive drugs
- Others
Global Churg Strauss Syndrome Market, by End-User
- Laboratories
- Hospitals
- Clinics
- Therapeutic usage
Global Churg Strauss Syndrome Market, by Region
Americas
- North America
- US
- Canada
- South America
Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Middle East & Africa
Intended Audience
- Hospitals and clinics
- Laboratories and associations
- Healthcare providers
- Medical device manufacturers
- Research institutes and academic centers
- Government associations
- Market research and consulting
Churg Strauss Syndrome Market Highlights:
